Inhibrx Biosciences, Inc. (INBX) vs Tyra Biosciences, Inc. (TYRA)
Inhibrx Biosciences, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Inhibrx Biosciences, Inc. and Tyra Biosciences, Inc. are of similar size ($1.5B and $1.5B). Across the 9 metrics below, Tyra Biosciences, Inc. leads on 5 and Inhibrx Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | INBX | TYRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,773.60%) | (45.31%) | (57.72%) |
| Return on assets | (75.44%) | (42.15%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack